[68Ga]Ga-DWJ155

DIAGNOSTIC_TEST3 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Advanced Breast CancerAdvanced Gastroesophageal AdenocarcinomaAdvanced Non-small Cell Lung CancerBladder CancerBreast CancerBreast NeoplasmsCarcinoma, Non-Small-Cell LungGastric/Gastroesophageal Junction (GEJ) Cancer

Phase 1

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

RecruitingNCT07117214

Novartis PharmaceuticalsBreast Neoplasms, Carcinoma, Non-Small-Cell Lung

Start: 2026-06-26End: 2029-01-26Target: 36Updated: 2026-08-27

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

RecruitingNCT07660055

Novartis PharmaceuticalsBladder Cancer, Breast Cancer, Gastric/Gastroesophageal Junction (GEJ) Cancer +1

Start: 2026-06-16End: 2032-05-24Target: 156Updated: 2026-08-27

A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors

RecruitingNCT07801508

Novartis PharmaceuticalsAdvanced Breast Cancer, Advanced Gastroesophageal Adenocarcinoma, Advanced Non-small Cell Lung Cancer +1

Start: 2026-09-22End: 2028-06-30Target: 66Updated: 2026-09-09